These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of the binding of thioflavin S to tau paired helical filaments. Santa-María I; Pérez M; Hernández F; Avila J; Moreno FJ J Alzheimers Dis; 2006 Aug; 9(3):279-85. PubMed ID: 16914838 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease. Watanabe H; Ono M; Kimura H; Matsumura K; Yoshimura M; Okamoto Y; Ihara M; Takahashi R; Saji H Bioorg Med Chem Lett; 2012 Sep; 22(17):5700-3. PubMed ID: 22832319 [TBL] [Abstract][Full Text] [Related]
6. Granular tau oligomers as intermediates of tau filaments. Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of tau aggregation induced by anionic and cationic dyes. Lira-De León KI; García-Gutiérrez P; Serratos IN; Palomera-Cárdenas M; Figueroa-Corona Mdel P; Campos-Peña V; Meraz-Ríos MA J Alzheimers Dis; 2013; 35(2):319-34. PubMed ID: 23435411 [TBL] [Abstract][Full Text] [Related]
8. QSAR studies for prediction of cross-β sheet aggregate binding affinity and selectivity. Cisek K; Kuret J Bioorg Med Chem; 2012 Feb; 20(4):1434-41. PubMed ID: 22285571 [TBL] [Abstract][Full Text] [Related]
9. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514 [TBL] [Abstract][Full Text] [Related]
11. Stacked binding of a PET ligand to Alzheimer's tau paired helical filaments. Merz GE; Chalkley MJ; Tan SK; Tse E; Lee J; Prusiner SB; Paras NA; DeGrado WF; Southworth DR Nat Commun; 2023 May; 14(1):3048. PubMed ID: 37236970 [TBL] [Abstract][Full Text] [Related]
12. Molecules of the quinoline family block tau self-aggregation: implications toward a therapeutic approach for Alzheimer's disease. Navarrete LP; Guzmán L; San Martín A; Astudillo-Saavedra L; Maccioni RB J Alzheimers Dis; 2012; 29(1):79-88. PubMed ID: 22232002 [TBL] [Abstract][Full Text] [Related]
13. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. King ME; Ahuja V; Binder LI; Kuret J Biochemistry; 1999 Nov; 38(45):14851-9. PubMed ID: 10555967 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's-disease-associated conformation of intrinsically disordered tau protein studied by intrinsically disordered protein liquid-phase competitive enzyme-linked immunosorbent assay. Skrabana R; Skrabanova-Khuebachova M; Kontsek P; Novak M Anal Biochem; 2006 Dec; 359(2):230-7. PubMed ID: 17081491 [TBL] [Abstract][Full Text] [Related]
15. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Bramblett GT; Trojanowski JQ; Lee VM Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956 [TBL] [Abstract][Full Text] [Related]
16. Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping. Larbig G; Pickhardt M; Lloyd DG; Schmidt B; Mandelkow E Curr Alzheimer Res; 2007 Jul; 4(3):315-23. PubMed ID: 17627489 [TBL] [Abstract][Full Text] [Related]
17. The role of tau oligomers in the onset of Alzheimer's disease neuropathology. Cárdenas-Aguayo Mdel C; Gómez-Virgilio L; DeRosa S; Meraz-Ríos MA ACS Chem Neurosci; 2014 Dec; 5(12):1178-91. PubMed ID: 25268947 [TBL] [Abstract][Full Text] [Related]
18. The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments. Crowe A; Ksiezak-Reding H; Liu WK; Dickson DW; Yen SH Am J Pathol; 1991 Dec; 139(6):1463-70. PubMed ID: 1721492 [TBL] [Abstract][Full Text] [Related]
19. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Friedhoff P; Schneider A; Mandelkow EM; Mandelkow E Biochemistry; 1998 Jul; 37(28):10223-30. PubMed ID: 9665729 [TBL] [Abstract][Full Text] [Related]
20. Molecular "light switch" [Ru(phen)2dppzidzo](2+) monitoring the aggregation of tau. Gao X; Wang L; Huang HL; Wang LL; Yao JL; Shi S; Yao TM Analyst; 2015 Nov; 140(22):7513-7. PubMed ID: 26460552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]